PSYC's September Newsletter Reflects Most Riveting Edition to Date and Highlights Industry Growth
Newsletter Reflects Most Riveting Edition to Date and Highlights
LAS VEGAS, NV -- September 15,
2020 -- InvestorsHub NewsWire -- Global Trac Solutions, Inc.
PSYC) (“Global” “PSYC” or the “Company”) is pleased to announce
that as a result of the Company’s success with expanding its
network within the emerging industry of medicinal psychedelics, it
has effectively constructed what the Company believes to be its
most compelling and dynamic newsletter to date, and further
demonstrating PSYC’s continued emergence as a digital media leader
within this fascinating sector.
Released this morning to its
growing base of subscribers, the first of its two September
editions of Microdose Monthly showcases exclusive interviews with
retired National Hockey League enforcer, Riley Cote, Paul F.
Austin, CEO and Founder of The Third Wave, and a follow-up interview with
Ronan Levy, Founder and Executive Chairman of Field
Trip Health, each of which were conducted by PSYC CEO, David
Flores. Also featured in the newsletter are stimulating articles
written by Psychedelic Spotlight Content Director, Kent
Sligh, and other content contributors whom PSYC has partnered with
to cover industry-relevant subject matter.
Said Global Trac Solutions, Inc.
CEO, David Flores: “I truly believe that the quality of content we
have been able to include in this edition of our Microdose Monthly
newsletter is a reflection of the hard-work and dedication my team
and I have been focused on with expanding our network and identity
within the psychedelic industry. We are positively determined to
establish Psychedelic Spotlight as not just a recognized
brand, but a reputable source within this space that, through the
engaging and knowledgeable information we develop and share,
contributes to its ongoing progress and momentum. Connecting with
other thought-leaders and passionate advocates within this space
is, in my opinion, a critical component to our own internal growth
and development. More specifically, expanding our network and
establishing new connections may, in some instances, be an
effective tool for exploring and identifying potential
collaborative opportunities as well as other fascinating
opportunities that may contribute to our growth from a monetization
perspective. Fostering our development as a digital media leader in
this industry is most certainly a core focus of mine currently.
However, my long-term goals are far more ambitious, and I am very
encouraged with the progress and direction we are moving
As the Company continues its
efforts of expanding its development of exclusive industry-focused
content, it encourages those who have not yet subscribed to
Microdose Monthly to do so by visiting https://www.psychedelicspotlight.com/.
About Global Trac Solutions, Inc.
At Global Trac Solutions we are
integrating media, creativity, and technology to develop and deploy
thought-provoking ideas and solutions that are fostering and
transforming the approach to some of society’s most pressing
PSYC has expressed its intent and
commitment to positioning itself at the forefront of the
psychedelic revolution and as a resource center for discovering and
understanding the latest research and business opportunities
surrounding psychedelic inspired medicines. In conjunction with the
FDA’s more open-minded approach to psychedelic medicines, and as
several major U.S. cities continue to approve the decriminalization
of psilocybin, investors are speculating that the psychedelic boom
could be bigger than that of cannabis. PSYC is your source for
current investment related news specific to psychedelic medicines
and cutting-edge research improving overall health, moving this
sector into the mainstream.
We believe in a forward-thinking
approach that embraces groundbreaking new technology and
innovations and through the vision of business development we
intend to continue to evolve into these unchartered territories as
the industry leaders of the future. We truly are the right TRAC to
This press release contains
forward-looking statements within the meaning of Section 27A of the
Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934, as amended. In some cases, you can
identify forward-looking statements by the following words:
"anticipate," "believe," "continue," "could," "estimate," "expect,"
"intend," "may," "ongoing," "plan," "potential," "predict,"
"project," "should," "will," "would," or the negative of these
terms or other comparable terminology, although not all
forward-looking statements contain these words. Forward-looking
statements are not a guarantee of future performance or results and
will not necessarily be accurate indications of the times at, or
by, which such performance or results will be achieved.
Forward-looking statements are based on information available at
the time the statements are made and involve known and unknown
risks, uncertainty and other factors that may cause our results,
levels of activity, performance or achievements to be materially
different from the information expressed or implied by the
forward-looking statements in this press release. This press
release should be considered in light of all filings of the Company
that are disclosed on the OTC Markets.com
Disclaimer: Global Trac
Solutions, Inc. does not in any way encourage or condone the use,
purchase, sale or transfer of any illegal substances, nor do we
encourage or condone partaking in any unlawful activities. We
support a harm reduction approach for the purpose of education and
promoting individual and public safety. If you are choosing to use
psychedelic substances, please do so
Global Trac Solutions, Inc.